AAAAAA
Results:
1-7
|
Results: 7
Authors:
Jakse, G
Hall, R
Bono, A
Holtl, W
Carpentier, P
Spaander, JP
van der Meijden, APM
Sylvester, R
Citation: G. Jakse et al., Intravesical BCG in patients with carcinoma in situ of the urinary bladder: Long-term results of EORTC GU group phase II protocol 30861, EUR UROL, 40(2), 2001, pp. 144-150
Authors:
van der Meijden, APM
Brausi, M
Zambon, V
Kirkels, W
de Balincourt, C
Sylvester, R
Citation: Apm. Van Der Meijden et al., Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: A European organization for research andtreatment of cancer genito-urinary group randomized phase III trial, J UROL, 166(2), 2001, pp. 476-481
Authors:
van der Meijden, APM
Citation: Apm. Van Der Meijden, Non-specific immunotherapy with bacille Calmette-Guerin (BCG), CLIN EXP IM, 123(2), 2001, pp. 179-180
Authors:
van der Meijden, APM
Citation: Apm. Van Der Meijden, Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor - Editorial comment, EUR UROL, 37(3), 2000, pp. 274-274
Authors:
Kurth, KH
Bouffioux, C
Sylvester, R
van der Meijden, APM
Oosterlinck, W
Brausi, M
Citation: Kh. Kurth et al., Treatment of superficial bladder tumors: Achievements and needs, EUR UROL, 37, 2000, pp. 1-9
Authors:
van der Meijden, APM
Citation: Apm. Van Der Meijden, Review on bladder cancer - Reply, BR MED J, 318(7187), 1999, pp. 875
Authors:
van der Meijden, APM
Citation: Apm. Van Der Meijden, Practical aspects of clinical trials on chemoprevention of prostate cancer, EUR UROL, 35(5-6), 1999, pp. 515-518
Risultati:
1-7
|